# Tadalafil-Delivra and Raynaud's Phenomenon

> **NCT03393325** · — · WITHDRAWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's**

## Conditions studied

- Raynaud Phenomenon

## Interventions

- **OTHER:** Observation of treatment with Tadalafil-Delivra

## Key facts

- **NCT ID:** NCT03393325
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-10
- **Primary completion:** 2019-06
- **Final completion:** 2019-09
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Sponsor decision. The study is not anticipated to start
- **Last updated:** 2018-09-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03393325

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03393325, "Tadalafil-Delivra and Raynaud's Phenomenon". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT03393325. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*